Urinary Incontinence (Stress, Urge, Overflow)
Involuntary loss of urine; classified by mechanism into stress, urge, mixed, and overflow.
Also known as: urinary incontinence, stress incontinence, urge incontinence, overactive bladder, overflow incontinence
Overview
Involuntary leakage of urine. Categorized by mechanism: stress (with increased intra-abdominal pressure), urge (sudden compelling need with leakage — overactive bladder), mixed (features of both), overflow (incomplete emptying with continuous dribbling), and functional (intact urinary system but barriers to toileting).
Epidemiology
Affects ~20-50% of community-dwelling women and increases with age; ~17% of women aged 18-44, >30% over age 60. Stress incontinence predominates in younger women; urge incontinence and mixed types predominate in older women and men with BPH-related urinary symptoms.
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Urinary Incontinence (Stress, Urge, Overflow) outline — plus all 514 diagnoses, 5,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Risk factors
- Female sex (stress incontinence; multifactorial)
- Age (collagen loss, detrusor changes, comorbidities)
- Parity, vaginal childbirth, obstetric injury
- Obesity (intra-abdominal pressure)
- Pelvic surgery, radiation
- Menopause (estrogen deficiency, urogenital atrophy)
- Neurologic disease: stroke, multiple sclerosis, spinal cord injury, Parkinson, dementia
- Medications: diuretics (urge), alpha-blockers (stress in women), sedatives (functional), opioids (overflow)
- Diabetes (neurogenic bladder), prostatic enlargement (overflow), cognitive impairment
Pathophysiology
Stress: urethral hypermobility or intrinsic sphincter deficiency allows leakage when intra-abdominal pressure (cough, sneeze, exertion) exceeds urethral closure pressure. Urge: detrusor overactivity — involuntary detrusor contractions, often idiopathic or related to neurologic disease. Overflow: chronic urinary retention from outlet obstruction (BPH, stricture) or detrusor underactivity (diabetes, neurogenic) causes high post-void residual and continuous overflow leakage. Functional: cognitive or mobility impairment prevents timely toileting.
Clinical presentation
Symptoms
- Stress: leakage with cough, sneeze, laugh, exertion, position change
- Urge: sudden compelling need to void with inability to defer; large-volume leakage
- Mixed: features of both stress and urge
- Overflow: continuous or post-void dribbling; weak stream; sensation of incomplete emptying; nocturia
- Functional: leakage due to inability to reach toilet (mobility, cognition)
Signs / physical exam
- Pelvic exam (women): atrophic vaginitis, prolapse (cystocele, rectocele, uterine prolapse), urethral hypermobility (Q-tip test), pelvic floor strength
- Cough stress test — direct leakage with cough at full bladder is diagnostic for stress incontinence
- Abdominal exam: distended bladder suggests retention/overflow
- DRE in men: enlarged prostate, masses
- Neurologic exam: focal deficits, anal sphincter tone (S2-S4)
- Post-void residual (PVR) — bladder scan or catheter; >150-200 mL suggests retention
Classic findings
Postmenopausal woman with leakage when coughing or laughing = stress incontinence. Sudden urge with leakage en route to bathroom = urge incontinence.
Differential diagnosis
- UTI — Acute onset, dysuria, frequency; positive UA/culture; reversible cause of incontinence
- Bladder cancer — Painless hematuria, smoking history; cystoscopy
- Vaginal/urethral fistula — Continuous urine leakage from vagina; history of pelvic surgery/childbirth; dye test or imaging
- Pelvic organ prolapse — Vaginal bulge sensation, mass on Valsalva, may worsen or 'mask' incontinence
- Neurogenic bladder — Spinal cord lesion, MS, diabetes; urodynamic abnormality
- BPH (men) — Obstructive and irritative symptoms; enlarged prostate; elevated PVR
- Detrusor sphincter dyssynergia — Spinal cord injury between brainstem and sacral cord; urodynamic study diagnostic
Diagnostic workup
Diagnostic criteria
Clinical diagnosis based on history, exam, and basic testing (UA, PVR). Urodynamic studies reserved for refractory cases, mixed picture, neurogenic suspicion, or pre-surgical evaluation. Voiding diary (3-day) quantifies severity and pattern.
Labs
- Urinalysis with microscopy — exclude infection, hematuria (bladder cancer)
- BMP — assess renal function, glucose (poorly controlled diabetes contributes)
- Urine culture if pyuria
Imaging
- Post-void residual (PVR) via bladder scan or catheterization — >150-200 mL suggests overflow
- Pelvic ultrasound or MRI if pelvic floor disorder, prolapse, or anatomic abnormality suspected
- Urodynamic studies — for unclear diagnosis, treatment failure, before invasive treatment
Diagnostic algorithm
| Type | Trigger | Mechanism | First-line Treatment |
|---|---|---|---|
| Stress | Cough, sneeze, exertion | Urethral hypermobility / sphincter deficiency | Kegels, weight loss, pessary, midurethral sling |
| Urge | Sudden compelling need | Detrusor overactivity | Bladder training, antimuscarinic, mirabegron |
| Mixed | Both | Both | Address most bothersome first |
| Overflow | Continuous dribbling | Retention (obstruction or underactive detrusor) | Treat cause (BPH, neurogenic); CIC if needed |
| Functional | Mobility/cognitive | Intact urinary system | Scheduled toileting, OT, environmental aids |
Treatment
First-line
- Lifestyle: weight loss (especially for stress incontinence), fluid management, caffeine and alcohol reduction, smoking cessation
- Bladder training (timed voiding, urge suppression techniques) — for urge incontinence
- Pelvic floor muscle training (Kegel exercises) ± biofeedback — first-line for stress incontinence (60-70% improvement)
- Stress incontinence:
- Pessary or urethral plug — non-surgical mechanical support
- Midurethral sling (TVT, TVT-O) — most effective definitive treatment
- Bulking agents (collagen, calcium hydroxylapatite) — less invasive option
- Urge incontinence / overactive bladder:
- Behavioral therapy first
- Antimuscarinic — oxybutynin, tolterodine, solifenacin, darifenacin, trospium, fesoterodine (caution in elderly — cognitive side effects)
- Beta-3 agonist — mirabegron, vibegron (preferred in elderly; no cognitive risk; check BP)
- Vaginal estrogen for postmenopausal women with urogenital atrophy
Second-line / adjunct
- Refractory urge incontinence:
- Onabotulinumtoxin A intravesical injection — for refractory OAB
- Sacral neuromodulation (InterStim)
- Percutaneous tibial nerve stimulation (PTNS)
- Overflow incontinence:
- Treat obstruction (alpha-blocker — tamsulosin, alfuzosin, silodosin — for BPH; 5-alpha-reductase inhibitor — finasteride, dutasteride; surgery if refractory)
- Clean intermittent catheterization for underactive detrusor
- Functional incontinence: occupational therapy, scheduled toileting, environmental modifications, caregiver education
- Avoid culprit medications when possible (diuretics, alpha-blockers in women, anticholinergics in elderly)
Complications
- Quality of life impact: social isolation, depression, sexual dysfunction
- Skin breakdown, dermatitis, pressure ulcers
- Recurrent UTI (especially overflow)
- Falls (rushing to bathroom, nocturia)
- Caregiver burden, institutionalization
- Hydronephrosis and renal impairment from chronic retention
- Treatment-related: antimuscarinic side effects (dry mouth, constipation, cognitive impairment), surgical complications
PANCE pearls
- PVR is essential to distinguish overflow from other types — a key step in workup of any incontinence presentation, especially in older adults.
- First-line for stress incontinence: pelvic floor muscle training (Kegels). Midurethral sling is the most effective definitive treatment.
- Antimuscarinics (oxybutynin in particular) are on the AGS Beers criteria — high risk of cognitive impairment, dementia, and falls in elderly. Prefer mirabegron or vibegron in older adults.
- Mixed incontinence: treat the most bothersome component first.
- Reversible causes (DIAPPERS): Delirium, Infection, Atrophic vaginitis, Pharmaceuticals, Psychiatric, Excess urine output, Restricted mobility, Stool impaction.
- Overflow incontinence in a man = consider BPH; in a diabetic = consider neurogenic bladder; bladder scan PVR confirms.
References
- AUA/SUFU 2019 — Surgical Treatment of Female Stress Urinary Incontinence: AUA/SUFU Guideline (Kobashi et al., J Urol 2017, amended 2019)
- AUA/SUFU 2024 — Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2024
- ACOG 2019 — ACOG Practice Bulletin No. 155: Urinary Incontinence in Women
Practice Renal/Urology questions on FirstPassPA
Turn this outline into retention. 5,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Start studying free → Browse all 514 diagnosesEducational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.